Private Equity

Updated:

Swanhill Capital

Swanhill Capital is a partnership that invests in health care companies from seed rounds to traditional LBOs. It has made three investments, including a Series...

Swanhill Capital logo

Swanhill Capital

Swanhill Capital is a partnership that invests in health care companies from seed rounds to traditional LBOs. It has made three investments, including a Series A investment in 1DOC3 on April 1, 2022. The firm has one portfolio exit, Cohero Health, which was exited on November 4, 2020.

General information

Firm type

Private Equity

Year founded

2007

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Frequently asked questions

What is Swanhill Capital's investment strategy?

Swanhill Capital's public record lists a multi-stage private equity strategy spanning seed and early-stage venture, growth and late-stage expansion, buyouts, and restructuring. The firm operates a balanced mandate that can deploy capital across the full company lifecycle, from founding through to control acquisitions and turnarounds. No public information confirms whether these strategies are executed through a single fund, separate vehicles, or a deal-by-deal structure.

Who makes investment decisions at Swanhill Capital?

The firm has not disclosed its principals, investment committee members, or any named decision-makers on its website or through public filings. Swanhill Capital maintains an intentionally low public profile, which suggests its limited partners interact directly with senior leadership through private channels. Any due diligence on the team would require a direct introduction.

Does Swanhill Capital publish its portfolio companies?

No. Swanhill Capital has not published a portfolio page, disclosed any named holdings, or announced transactions through press releases or regulatory filings. The firm appears to operate without public portfolio disclosure, which is uncommon among SEC-registered investment advisers but consistent with a family-office or exempt-reporting-adviser structure, though its exact regulatory filing status is not confirmed in public records.

How does Swanhill Capital source its deals?

Given its minimal public footprint, Swanhill Capital likely relies on a proprietary network for deal sourcing rather than competitive auction processes or inbound pitch decks. The firm's presence in New York and its unadvertised profile point to a relationship-driven model where deal flow comes through principals' personal networks, co-investor relationships, and direct founder introductions.

Why does Swanhill Capital have such a limited public presence?

Swanhill Capital's near-total absence from public view — no team page, no portfolio, no press coverage, no LinkedIn — is a deliberate choice common among firms that manage capital for a small number of ultra-high-net-worth families or a single principal. This structure allows maximum investment flexibility and confidentiality but makes institutional due diligence dependent on direct access to the firm.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles